![The costs of diabetes treatment in low- and middle-income countries: a systematic review | BMJ Global Health The costs of diabetes treatment in low- and middle-income countries: a systematic review | BMJ Global Health](https://gh.bmj.com/content/bmjgh/4/1/e001258/F2.large.jpg)
The costs of diabetes treatment in low- and middle-income countries: a systematic review | BMJ Global Health
![Choice across 10 pharmacologic combination strategies for type 2 diabetes: a cost-effectiveness analysis | BMC Medicine | Full Text Choice across 10 pharmacologic combination strategies for type 2 diabetes: a cost-effectiveness analysis | BMC Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12916-020-01837-x/MediaObjects/12916_2020_1837_Fig1_HTML.png)
Choice across 10 pharmacologic combination strategies for type 2 diabetes: a cost-effectiveness analysis | BMC Medicine | Full Text
![Rising Costs of Drug/Insulin Treatment for Diabetes: A Perspective from India | Diabetes Technology & Therapeutics Rising Costs of Drug/Insulin Treatment for Diabetes: A Perspective from India | Diabetes Technology & Therapeutics](https://www.liebertpub.com/cms/10.1089/dia.2017.0286/asset/images/medium/figure1.gif)
Rising Costs of Drug/Insulin Treatment for Diabetes: A Perspective from India | Diabetes Technology & Therapeutics
![IJERPH | Free Full-Text | Use of Diabetes Treatment Satisfaction Questionnaire in Diabetes Care: Importance of Patient-Reported Outcomes IJERPH | Free Full-Text | Use of Diabetes Treatment Satisfaction Questionnaire in Diabetes Care: Importance of Patient-Reported Outcomes](https://www.mdpi.com/ijerph/ijerph-15-00947/article_deploy/html/images/ijerph-15-00947-g001.png)
IJERPH | Free Full-Text | Use of Diabetes Treatment Satisfaction Questionnaire in Diabetes Care: Importance of Patient-Reported Outcomes
![Diabetes-Related Effectiveness and Cost of Liraglutide or Insulin in German Patients with Type 2 Diabetes: A 5-Year Retrospective Claims Analysis | SpringerLink Diabetes-Related Effectiveness and Cost of Liraglutide or Insulin in German Patients with Type 2 Diabetes: A 5-Year Retrospective Claims Analysis | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs13300-020-00903-0/MediaObjects/13300_2020_903_Fig6_HTML.png)
Diabetes-Related Effectiveness and Cost of Liraglutide or Insulin in German Patients with Type 2 Diabetes: A 5-Year Retrospective Claims Analysis | SpringerLink
![The state of diabetes treatment coverage in 55 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 680 102 adults - The Lancet Healthy Longevity The state of diabetes treatment coverage in 55 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 680 102 adults - The Lancet Healthy Longevity](https://www.thelancet.com/cms/attachment/ee9a3cd7-aea4-48bc-b58c-d42d793e7edd/gr1_lrg.jpg)
The state of diabetes treatment coverage in 55 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 680 102 adults - The Lancet Healthy Longevity
![The costs of diabetes treatment in low- and middle-income countries: a systematic review | BMJ Global Health The costs of diabetes treatment in low- and middle-income countries: a systematic review | BMJ Global Health](https://gh.bmj.com/content/bmjgh/4/1/e001258/F4.large.jpg)